AU774681B2 - Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders - Google Patents
Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders Download PDFInfo
- Publication number
- AU774681B2 AU774681B2 AU28678/99A AU2867899A AU774681B2 AU 774681 B2 AU774681 B2 AU 774681B2 AU 28678/99 A AU28678/99 A AU 28678/99A AU 2867899 A AU2867899 A AU 2867899A AU 774681 B2 AU774681 B2 AU 774681B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- substituted
- group
- nrr
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 *C(SC[C@](C(N1[C@]2CCC1)=O)NC2=O)=N Chemical compound *C(SC[C@](C(N1[C@]2CCC1)=O)NC2=O)=N 0.000 description 14
- SZWFKJNYXQAMSV-WDSKDSINSA-N O=C([C@H]1N2CCC1)N[C@@H](CS)C2=O Chemical compound O=C([C@H]1N2CCC1)N[C@@H](CS)C2=O SZWFKJNYXQAMSV-WDSKDSINSA-N 0.000 description 2
- ZWUUSIJAGZQXKP-OALUTQOASA-N CCCCc1cc(C[C@@H](C(N2[C@H]3CCC2)=O)NC3=O)cc(CCCC)c1O Chemical compound CCCCc1cc(C[C@@H](C(N2[C@H]3CCC2)=O)NC3=O)cc(CCCC)c1O ZWUUSIJAGZQXKP-OALUTQOASA-N 0.000 description 1
- SAVMCVRAGPXJMO-OGWRGKRKSA-N CCCCc1cc([C@H](C2)C2(C(N2[C@H]3CCC2)=O)NC3O)cc(CCCC)c1O Chemical compound CCCCc1cc([C@H](C2)C2(C(N2[C@H]3CCC2)=O)NC3O)cc(CCCC)c1O SAVMCVRAGPXJMO-OGWRGKRKSA-N 0.000 description 1
- XFCOMCMVFZBBEP-YUMQZZPRSA-N N=C(NCCC[C@@H](C(N1[C@H]2CCC1)=O)NC2=O)S Chemical compound N=C(NCCC[C@@H](C(N1[C@H]2CCC1)=O)NC2=O)S XFCOMCMVFZBBEP-YUMQZZPRSA-N 0.000 description 1
- XRSWPGAAQHWNLS-IUCAKERBSA-N O=C([C@H]1N2CCC1)N[C@@H](C[n]1cncc1)C2=O Chemical compound O=C([C@H]1N2CCC1)N[C@@H](C[n]1cncc1)C2=O XRSWPGAAQHWNLS-IUCAKERBSA-N 0.000 description 1
- DZCFRGDPUSYCAJ-SBVGRVNTSA-N OC(C(C1)([C@H]1c1cnc[nH]1)N1)N(CCC2)[C@@H]2C1=O Chemical compound OC(C(C1)([C@H]1c1cnc[nH]1)N1)N(CCC2)[C@@H]2C1=O DZCFRGDPUSYCAJ-SBVGRVNTSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2218498A | 1998-02-11 | 1998-02-11 | |
| US09/022184 | 1998-02-11 | ||
| US9578898P | 1998-08-07 | 1998-08-07 | |
| US60/095788 | 1998-08-07 | ||
| US09/246,307 US7202279B1 (en) | 1998-02-11 | 1999-02-08 | Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| US09/246307 | 1999-02-08 | ||
| PCT/US1999/003147 WO1999040931A1 (en) | 1998-02-11 | 1999-02-10 | Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2867899A AU2867899A (en) | 1999-08-30 |
| AU774681B2 true AU774681B2 (en) | 2004-07-01 |
Family
ID=27361814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28678/99A Ceased AU774681B2 (en) | 1998-02-11 | 1999-02-10 | Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7202279B1 (OSRAM) |
| EP (1) | EP1061936A4 (OSRAM) |
| JP (1) | JP4443763B2 (OSRAM) |
| AU (1) | AU774681B2 (OSRAM) |
| CA (1) | CA2320378A1 (OSRAM) |
| WO (1) | WO1999040931A1 (OSRAM) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605623B1 (en) | 1998-12-18 | 2003-08-12 | Bristol-Myers Squibb Pharma Co. | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| AU2001279313B2 (en) | 2000-08-04 | 2007-03-01 | Ampio Pharmaceuticals, Inc. | Method of using diketopiperazines and composition containing them |
| AU2001284697A1 (en) | 2000-08-04 | 2002-02-18 | Dmi Biosciences, Inc. | Method of synthesizing diketopiperazines |
| ATE520981T1 (de) | 2002-10-02 | 2011-09-15 | Dmi Biosciences Inc | Diagnose und überwachung von krankheiten |
| US7335644B2 (en) * | 2003-03-31 | 2008-02-26 | Council Of Scientific And Industrial Research | Anti-hypertensive molecules and process for preparation thereof |
| CA3050734A1 (en) | 2003-05-15 | 2004-12-02 | Ampio Pharmaceuticals, Inc. | Treatment of t-cell mediated diseases |
| SI1664050T1 (sl) * | 2003-09-03 | 2016-04-29 | Neuren Pharmaceuticals Limited | Nevroprotektične biciklične spojine in farmacevtski sestavki, vsebujoči le-te |
| US8791117B2 (en) | 2003-09-03 | 2014-07-29 | Neuren Pharmaceuticals Limited | Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals |
| WO2008109445A1 (en) * | 2007-03-02 | 2008-09-12 | Preventive Nutrient Company, Inc. | Compositions and methods for treating alzheimer's disease and dementia |
| EP2252596B1 (en) * | 2008-02-07 | 2016-12-28 | Marquette University | Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
| WO2009146320A1 (en) | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
| KR101137503B1 (ko) * | 2009-07-14 | 2012-04-20 | 웰이앤씨 주식회사 | 고분자 고체 지지체를 이용한 히스티딜-프롤린아미드 유도체의 제조 방법 |
| WO2011037644A1 (en) | 2009-09-25 | 2011-03-31 | Neuren Pharmaceuticals Limited | Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy |
| PH12012501300B1 (en) | 2009-12-25 | 2017-09-27 | Suntory Beverage & Food Asia Pte Ltd | Learning motivation improvers |
| US8507496B2 (en) | 2010-09-07 | 2013-08-13 | Dmi Acquisition Corp. | Treatment of diseases |
| EA027343B1 (ru) | 2011-10-10 | 2017-07-31 | Ампио Фармасьютикалз, Инк. | Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования |
| EP2766029B1 (en) | 2011-10-10 | 2020-03-25 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
| CA2846394A1 (en) | 2011-10-28 | 2013-05-02 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
| CN104870452B (zh) * | 2012-10-22 | 2018-04-13 | 希望之城 | Etp衍生物 |
| BR112015020469A2 (pt) | 2013-03-15 | 2020-01-28 | Ampio Pharmaceuticals Inc | Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo |
| AU2015305611B2 (en) | 2014-08-18 | 2020-04-23 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
| US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
| JPWO2017119481A1 (ja) * | 2016-01-08 | 2018-11-08 | サントリーホールディングス株式会社 | 環状ジペプチド含有神経性疾患予防用組成物 |
| US20190201395A1 (en) * | 2016-05-26 | 2019-07-04 | Amino Up Chemical Co., Ltd. | Sleep improving agent |
| EP3478676A1 (en) | 2016-06-29 | 2019-05-08 | Orion Corporation | Benzodioxane derivatives and their pharmaceutical use |
| JP7088912B2 (ja) | 2016-09-15 | 2022-06-21 | シティ・オブ・ホープ | ジチオｅｔｐ誘導体 |
| JP7020797B2 (ja) * | 2017-04-25 | 2022-02-16 | キリンホールディングス株式会社 | 自律神経調節用組成物 |
| ES2964549T3 (es) * | 2018-07-10 | 2024-04-08 | Novmetapharma Co Ltd | Nuevas formas polimórficas de ciclo (-His-Pro) |
| US11820834B2 (en) | 2018-07-10 | 2023-11-21 | Novmetapharma Co., Ltd. | Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney disease |
| KR102133151B1 (ko) | 2019-03-28 | 2020-07-13 | 주식회사 노브메타파마 | Chp(사이클로-히스프로)를 포함하는 복막 섬유증의 예방, 개선 또는 치료용 조성물 |
| WO2021195265A1 (en) | 2020-03-24 | 2021-09-30 | Ampio Pharmaceuticals, Inc. | Methods for treating diseases associated with respiratory viruses |
| US12053467B2 (en) * | 2020-12-18 | 2024-08-06 | NovMeta Pharma Co., Ltd. | Method of treating fibrosis |
| WO2024262349A1 (ja) * | 2023-06-19 | 2024-12-26 | サントリーホールディングス株式会社 | 認知機能の低下抑制又は改善用組成物、及び、β－セクレターゼ阻害用組成物 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5564609A (en) * | 1994-12-29 | 1996-10-15 | Takatori Corporation | Method for mounting pantyhose blanks |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1583797A (OSRAM) * | 1967-04-12 | 1969-12-05 | ||
| CS231227B1 (en) * | 1982-10-01 | 1984-10-15 | Evzen Kasafirek | 2,5-pierazindion derivatives |
| CA1256650A (en) * | 1983-03-25 | 1989-06-27 | Toshinari Tamura | Process of producing 2-azetidinone-4-substituted compounds, and medicaments containing the compounds |
| WO1994006794A1 (en) * | 1992-09-24 | 1994-03-31 | National Institutes Of Health | Aralkyl diazabicycloalkane derivatives for cns disorders |
| EP0627219A1 (en) | 1993-05-25 | 1994-12-07 | Daiichi Pharmaceutical Co., Ltd. | Use of calmodulin inhibitors for neuroprotection |
| US5859001A (en) | 1996-01-11 | 1999-01-12 | University Of Florida Research Foundation, Inc. | Neuroprotective effects of polycyclic phenolic compounds |
| US6310052B1 (en) | 1996-06-04 | 2001-10-30 | Queen's University At Kingston | Nitrate esters and their use for neurological conditions |
| GB9915437D0 (en) | 1999-07-01 | 1999-09-01 | Cerebrus Ltd | Chemical compounds III |
-
1999
- 1999-02-08 US US09/246,307 patent/US7202279B1/en not_active Expired - Fee Related
- 1999-02-10 AU AU28678/99A patent/AU774681B2/en not_active Ceased
- 1999-02-10 CA CA002320378A patent/CA2320378A1/en not_active Abandoned
- 1999-02-10 EP EP99909487A patent/EP1061936A4/en not_active Withdrawn
- 1999-02-10 WO PCT/US1999/003147 patent/WO1999040931A1/en not_active Ceased
- 1999-02-10 JP JP2000531182A patent/JP4443763B2/ja not_active Expired - Fee Related
-
2007
- 2007-02-22 US US11/709,456 patent/US8044103B2/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5564609A (en) * | 1994-12-29 | 1996-10-15 | Takatori Corporation | Method for mounting pantyhose blanks |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1061936A1 (en) | 2000-12-27 |
| US20070161640A1 (en) | 2007-07-12 |
| JP4443763B2 (ja) | 2010-03-31 |
| AU2867899A (en) | 1999-08-30 |
| WO1999040931A1 (en) | 1999-08-19 |
| CA2320378A1 (en) | 1999-08-19 |
| US8044103B2 (en) | 2011-10-25 |
| US7202279B1 (en) | 2007-04-10 |
| EP1061936A4 (en) | 2005-03-09 |
| JP2003525850A (ja) | 2003-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8044103B2 (en) | Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders | |
| JP6896113B2 (ja) | ジアザ二環式置換イミダゾピリミジンおよび呼吸障害を治療するためのその使用 | |
| AU2016366310B2 (en) | Improved apelin receptor (APJ) agonists and uses thereof | |
| DE60115227T2 (de) | Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga | |
| KR100296543B1 (ko) | 시토킨생산을유도하는우레탄및우레아,이의제조방법 | |
| EP1664050B1 (en) | Neuroprotective bicyclic compounds and pharmaceutical compositions containing them | |
| HU229371B1 (en) | Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof | |
| EP0184550A2 (de) | 5-Amino-4-hydroxyvalerylamid-Derivate | |
| US11142546B2 (en) | Neuropeptide S receptor (NPSR) agonists | |
| KR20190031518A (ko) | 치환된 디아자헤테로비시클릭 화합물 및 그의 용도 | |
| US8013170B2 (en) | Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damage | |
| JPH0811746B2 (ja) | 新規ペプチド化合物 | |
| AU2021201006A1 (en) | N-methyl-D-aspartate receptor modulators and methods of making and using same | |
| TW202330539A (zh) | 用於治療、預防或管理過度增生性病症之化合物、醫藥組合物及方法 | |
| US7863304B2 (en) | Analogs of glycyl-prolyl-glutamate | |
| JPH09505317A (ja) | 新規アミノ酸誘導体、それらの製造方法及びこれらの化合物を含有する医薬組成物 | |
| DE60010711T2 (de) | Amido-spiropiperidine promovieren die freisetzung von wachstumshormonen | |
| JP2005500253A (ja) | トロンビン受容体アンタゴニストとしてのアミノメチルピロロキナゾリン化合物 | |
| EP0299513A1 (en) | Azetidine derivatives, compositions and their use | |
| JPS59141544A (ja) | ラクタムペプチド及びその製造方法、並びに該ペプチドを含有する医薬 | |
| CA2049390A1 (en) | Novel peptide derivatives and their pharmaceutical use | |
| CA3018344C (en) | Neuropeptide s receptor (npsr) agonists | |
| DD239210A5 (de) | Verfahren zur herstellung neuer 5-amino-4-hydroxyvaleryl-derivate | |
| EP0186431B1 (en) | Anti-hypertensive octahydro-6-azaindole dipeptide derivatives | |
| WO2006104190A1 (ja) | Ｐａｒ－２アゴニスト |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |